<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="has been associated with large numbers of cases of severe" exact="neurologic disease," post="including Guillain-Barré syndrome and microcephaly. Despite its recent establishment"/>
 <result pre="with large numbers of cases of severe neurologic disease, including" exact="Guillain-Barré syndrome" post="and microcephaly. Despite its recent establishment as a serious"/>
 <result pre="large numbers of cases of severe neurologic disease, including Guillain-Barré" exact="syndrome" post="and microcephaly. Despite its recent establishment as a serious"/>
 <result pre="suitable assay for the identification of ZIKV inhibitors targeting the" exact="viral" post="polymerase using known broad-spectrum inhibitors. The assay was also"/>
 <result pre="activity by different RdRps, illustrated here using purified RdRps from" exact="hepatitis" post="C virus and foot-and-mouth disease virus. The potential of"/>
 <result pre="here using purified RdRps from hepatitis C virus and foot-and-mouth" exact="disease" post="virus. The potential of fluorescence-based approaches for the enzymatic"/>
 <result pre="The potential of fluorescence-based approaches for the enzymatic characterization of" exact="viral" post="polymerases, as well as for high-throughput screening of antiviral"/>
 <result pre="of this family also include the human pathogens dengue virus," exact="yellow fever" post="virus, West Nile virus, tick-borne encephalitis virus, Japanese encephalitis"/>
 <result pre="human pathogens dengue virus, yellow fever virus, West Nile virus," exact="tick-borne encephalitis" post="virus, Japanese encephalitis virus and hepatitis C virus (HCV)1."/>
 <result pre="pathogens dengue virus, yellow fever virus, West Nile virus, tick-borne" exact="encephalitis" post="virus, Japanese encephalitis virus and hepatitis C virus (HCV)1."/>
 <result pre="virus, yellow fever virus, West Nile virus, tick-borne encephalitis virus," exact="Japanese encephalitis" post="virus and hepatitis C virus (HCV)1. ZIKV is an"/>
 <result pre="yellow fever virus, West Nile virus, tick-borne encephalitis virus, Japanese" exact="encephalitis" post="virus and hepatitis C virus (HCV)1. ZIKV is an"/>
 <result pre="West Nile virus, tick-borne encephalitis virus, Japanese encephalitis virus and" exact="hepatitis" post="C virus (HCV)1. ZIKV is an arthropod-borne virus and"/>
 <result pre="also be spread perinatally3, sexually4 or by blood transfusions5. ZIKV" exact="infection" post="in humans is generally asymptomatic6,7; however, a significant proportion"/>
 <result pre="significant proportion of infected individuals (~20%) develop neurological conditions, including" exact="Guillain-Barré syndrome" post="(GBS), which is the most frequent cause of acute"/>
 <result pre="proportion of infected individuals (~20%) develop neurological conditions, including Guillain-Barré" exact="syndrome" post="(GBS), which is the most frequent cause of acute"/>
 <result pre="Guillain-Barré syndrome (GBS), which is the most frequent cause of" exact="acute" post="flaccid paralysis not associated with poliovirus in adults, and"/>
 <result pre="in newborns. An increase in the incidence of GBS and" exact="microcephaly" post="has been associated with outbreaks of ZIKV in Micronesia"/>
 <result pre="non-structural proteins are involved in the essential steps of the" exact="viral" post="replication cycle inside the host cell. Among them, NS5"/>
 <result pre="NS5 is the largest (903 amino acids) and most conserved" exact="viral" post="protein15. NS5 includes an N-terminal domain containing methyltransferase activity"/>
 <result pre="a C-terminal RNA-dependent RNA polymerase (RdRp) domain (residues 275–903). A" exact="short" post="linker interdomain formed by residues 263–274 covalently connects both"/>
 <result pre="and six conserved motifs (A–F) that are common to other" exact="viral" post="RdRps. These motifs are critical for its polymerase activity,"/>
 <result pre="– RNA-templated RNA synthesis versus conventional DNA-dependent DNA synthesis –" exact="viral" post="RdRps are key targets for direct-acting antiviral agents21. The"/>
 <result pre="progress, no drugs are yet licensed for the treatment of" exact="disease" post="caused by any mosquito-borne flavivirus, including ZIKV (for a"/>
 <result pre="was further established with RdRps from two distinct viruses: foot-and-mouth" exact="disease" post="virus (FMDV) and hepatitis C virus (HCV). The implications"/>
 <result pre="RdRps from two distinct viruses: foot-and-mouth disease virus (FMDV) and" exact="hepatitis" post="C virus (HCV). The implications of these results for"/>
 <result pre="[α-32P]GTP (250 μCi; 3000 Ci/mmol) were obtained from Perkin Elmer. FMDV" exact="viral" post="protein genome-linked 1 (VPg1) was synthetically prepared as previously"/>
 <result pre="E. coli BL21(DE3)-pRIL cells. After plasmid extraction from three independent" exact="bacterial" post="colonies, nucleotide sequencing determined that two DNA samples contained"/>
 <result pre="to confirm the presence of the expected insert and the" exact="absence of" post="undesired mutations. Expression and purification of viral polymerases For"/>
 <result pre="and the absence of undesired mutations. Expression and purification of" exact="viral" post="polymerases For the expression of ZIKV NS5 RdRp (hereafter"/>
 <result pre="at 4 °C and stored at −80 °C until further use. The" exact="bacterial" post="pellets recovered from 200 mL cultures were resuspended in 20 mL"/>
 <result pre="of the same reagents as described above, but in the" exact="absence of" post="dye. The reactions were quenched at 60 min by adding"/>
 <result pre="the nonspecific activity obtained in a control performed in the" exact="absence of" post="MnCl2. Results Purification and biochemical characterization of recombinant ZIKV"/>
 <result pre="3 hours; lanes 2 to 6). Polymerization assays performed in the" exact="absence of" post="enzyme (lane 1), in the presence of MgCl2 as"/>
 <result pre="presence of MgCl2 as metal donor (lane 7), in the" exact="absence of" post="any metal donor (lane 8), or using the GNN"/>
 <result pre="use of a homopolymeric ssRNA as a template in the" exact="absence of" post="any primer, since it has been previously demonstrated that"/>
 <result pre="polymerization products were resolved by PAGE. RNA synthesis in the" exact="absence of" post="primer was observed both in the presence of poly-U"/>
 <result pre="the presence of radioactive nucleotides that were less competent for" exact="viral" post="RNA synthesis: [α-32P]GTP to poly-U and [α-32P]ATP to poly-C."/>
 <result pre="dsRNA. It has been reported that SYTO 9 dye shows" exact="lower" post="interference on polymerization assays when binding to dsDNA44,45. In"/>
 <result pre="disruption of the catalytic site (RdRp GNN) also led to" exact="complete" post="loss of polymerase activity (Fig. 2B). Likewise, terminal transferase"/>
 <result pre="DTT, MnCl2 and enzyme) affected RdRp activity. The presence or" exact="absence of" post="DTT and NaCl in the assay had little effect"/>
 <result pre="analog that inhibits but does not terminate RNA elongation during" exact="viral" post="replication51–54). Both compounds reduced the polymerase activities (Fig. 3A)."/>
 <result pre="application39. Fluorescence-based activity assay can be adapted to monitor different" exact="viral" post="RdRps To investigate whether the assay can be adapted"/>
 <result pre="To investigate whether the assay can be adapted to other" exact="viral" post="polymerases, we used two unrelated RdRps from FMDV (3Dpol)"/>
 <result pre="RNA synthesis in vitro, in an assay primed by the" exact="viral" post="protein-primer VPg. It has been previously demonstrated that FMDV"/>
 <result pre="uridylylated, VPg can act as a competent primer to initiate" exact="viral" post="genome replication55,56. Vpg protein-primed polymerization in vitro can be"/>
 <result pre="in the presence of a catalytically-inactive protein, or in the" exact="absence of" post="Mn2+ or VPg1 (Fig. 4D). Overall, our data show"/>
 <result pre="this 96-well format assay can be exploited to characterize different" exact="viral" post="RdRps in vitro, as it permits real-time monitoring of"/>
 <result pre="coli BL21(DE3)-pRIL containing plasmid pET28-HCV NS5bΔ21 and grown in the" exact="absence of" post="IPTG is shown. Lane 2, same as lane 1"/>
 <result pre="assays in the presence of MgCl2 (lane 7), in the" exact="absence of" post="any metal donor (lane 8), or using GNN inactive"/>
 <result pre="activity. Lane 1 represents a negative control reaction in the" exact="absence of" post="enzyme. The position of the labeled non-incorporated nucleotide is"/>
 <result pre="is an urgent need to develop new treatments for ZIKV" exact="infection" post="and to control its rapid geographical spread. Different approaches"/>
 <result pre="differences in the mechanisms of replication between cellular DNA and" exact="viral" post="RNA genomes, the latter involving the synthesis of RNA"/>
 <result pre="of specific antiviral treatments. The use of antivirals against non-RdRp" exact="viral" post="polymerases, such as human immunodeficiency virus and hepatitis B"/>
 <result pre="use of antivirals against non-RdRp viral polymerases, such as human" exact="immunodeficiency" post="virus and hepatitis B virus reverse transcriptases, and herpes"/>
 <result pre="against non-RdRp viral polymerases, such as human immunodeficiency virus and" exact="hepatitis" post="B virus reverse transcriptases, and herpes virus DNA polymerase,"/>
 <result pre="human immunodeficiency virus and hepatitis B virus reverse transcriptases, and" exact="herpes" post="virus DNA polymerase, supports the suitability of this group"/>
 <result pre="an advantage of fluorescence-based methods over traditional approaches is the" exact="absence of" post="radioactive compounds, which facilitates their broad use in different"/>
 <result pre="an accurate determination of replication kinetics in the presence or" exact="absence of" post="the drug and the predicted affinity constants of the"/>
 <result pre="is not a chain terminator and its incorporation into the" exact="viral" post="RNA has been linked to an increase in transition"/>
 <result pre="these RNA-dye complexes might impede the effective elongation by the" exact="viral" post="RdRp. In conclusion, we have demonstrated that the procedures"/>
 <result pre="can be easily adapted to measure polymerization activity of several" exact="viral" post="RdRps, strengthening our method as a universal procedure for"/>
 <result pre="universal procedure for the development of high-throughput tools to characterize" exact="viral" post="polymerases (e.g., enzymology, polymerase variants of interest) and to"/>
 <result pre="(2014). 6.PetersenLRJamiesonDJPowersAMHoneinMAZika VirusN Engl J Med20163741552156310.1056/NEJMra160211327028561 7.LazearHMDiamondMSZika Virus: New Clinical" exact="Syndromes" post="and Its Emergence in the Western HemisphereJ Virol2016904864487510.1128/JVI.00252-1626962217 8.MlakarJet"/>
 <result pre="Defects–Reviewing the Evidence for CausalityN Engl J Med20163741981198710.1056/NEJMsr160433827074377 10.Cao-LormeauVMet al.Guillain-Barre" exact="Syndrome" post="outbreak associated with Zika virus infection in French Polynesia:"/>
 <result pre="Engl J Med20163741981198710.1056/NEJMsr160433827074377 10.Cao-LormeauVMet al.Guillain-Barre Syndrome outbreak associated with Zika" exact="virus infection" post="in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 11.GullandAZika virus is"/>
 <result pre="J Med20163741981198710.1056/NEJMsr160433827074377 10.Cao-LormeauVMet al.Guillain-Barre Syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: a case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 11.GullandAZika virus is"/>
 <result pre="Kedougou, and Zika virusesArch Virol200715268769610.1007/s00705-006-0903-z17195954 13.Yun, S. I. et al." exact="Complete" post="Genome Sequences of Three Historically Important, Spatiotemporally Distinct, and"/>
 <result pre="PRVABC-59. Genome Announc4, 10.1128/genomeA.00800-16 (2016). 14.Ladner, J. T. et al." exact="Complete" post="Genome Sequences of Five Zika Virus Isolates. Genome Announc4,"/>
 <result pre="dengue virusProc Natl Acad Sci USA2009106204352043910.1073/pnas.090701010619918064 23.GotteMFeldJJDirect-acting antiviral agents for" exact="hepatitis" post="C: structural and mechanistic insightsNat Rev Gastroenterol Hepatol20161333835110.1038/nrgastro.2016.6027147491 24.MaletHet"/>
 <result pre="a target for drug discoveryAntiviral Res2015119576710.1016/j.antiviral.2015.04.01025912817 26.EyerLet al.Nucleoside inhibitors of" exact="tick-borne encephalitis" post="virusAntimicrob Agents Chemother2015595483549310.1128/AAC.00807-1526124166 27.ChenHet al.Selective inhibition of the West"/>
 <result pre="target for drug discoveryAntiviral Res2015119576710.1016/j.antiviral.2015.04.01025912817 26.EyerLet al.Nucleoside inhibitors of tick-borne" exact="encephalitis" post="virusAntimicrob Agents Chemother2015595483549310.1128/AAC.00807-1526124166 27.ChenHet al.Selective inhibition of the West"/>
 <result pre="methyltransferase by nucleoside analogsAntiviral Res20139723223910.1016/j.antiviral.2012.12.01223267828 28.JulanderJGet al.Efficacy of 2′-C-methylcytidine against" exact="yellow fever" post="virus in cell culture and in a hamster modelAntiviral"/>
 <result pre="4th edn, (Cold Spring Harbor Laboratory Press, 2012). 35.AriasAet al.Mutant" exact="viral" post="polymerase in the transition of virus to error catastrophe"/>
 <result pre="site for RNA bindingJ Mol Biol20053531021103210.1016/j.jmb.2005.09.02216216271 36.Ferrer-OrtaCet al.Structure of foot-and-mouth" exact="disease" post="virus RNA-dependent RNA polymerase and its complex with a"/>
 <result pre="complex with a template-primer RNAJ Biol Chem2004279472124722110.1074/jbc.M40546520015294895 37.MarukianSet al.Cell culture-produced" exact="hepatitis" post="C virus does not infect peripheral blood mononuclear cellsHepatology2008481843185010.1002/hep.2255019003912"/>
 <result pre="Chem2004279472124722110.1074/jbc.M40546520015294895 37.MarukianSet al.Cell culture-produced hepatitis C virus does not infect" exact="peripheral" post="blood mononuclear cellsHepatology2008481843185010.1002/hep.2255019003912 38.AgudoRCalvoPAMartinez-JimenezMIBlancoLEngineering human PrimPol into an efficient"/>
 <result pre="human PrimPol into an efficient RNA-dependent-DNA primase/polymeraseNucleic Acids Res2017459046905810.1093/nar/gkx63328911121 39.ZhangJHChungTDOldenburgKRA" exact="Simple" post="Statistical Parameter for Use in Evaluation and Validation of"/>
 <result pre="chromatin-associated poly(A) synthesis in vitro by cordycepin 5′-triphosphateNature197726717818010.1038/267178a016073440 51.SierraMet al.Foot-and-mouth" exact="disease" post="virus mutant with decreased sensitivity to ribavirin: implications for"/>
 <result pre="by kinetic analysis of the polymerase encoded by a foot-and-mouth" exact="disease" post="virus mutant with reduced sensitivity to ribavirinJ Virol200882123461235510.1128/JVI.01297-0818829745 55.NayakAGoodfellowIGBelshamGJFactors"/>
 <result pre="ribavirinJ Virol200882123461235510.1128/JVI.01297-0818829745 55.NayakAGoodfellowIGBelshamGJFactors required for the Uridylylation of the foot-and-mouth" exact="disease" post="virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent"/>
 <result pre="al.Role of RNA structure and RNA binding activity of foot-and-mouth" exact="disease" post="virus 3C protein in VPg uridylylation and virus replicationJ"/>
 <result pre="screen to identify small compound inhibitors of the genotype 3a" exact="hepatitis" post="C virus RNA polymeraseJ Biomol Screen2013181027103410.1177/108705711348988323708123 62.NiyomrattanakitPet al.A fluorescence-based"/>
 <result pre="activityProc Natl Acad Sci USA2010107191511915610.1073/pnas.101359210720974907 66.MadhviAet al.A screen for novel" exact="hepatitis" post="C virus RdRp inhibitor identifies a broad-spectrum antiviral compoundSci"/>
 <result pre="antiviral compoundSci Rep20177581610.1038/s41598-017-04449-328725041 67.VoNVYoungKCLaiMMMutagenic and inhibitory effects of ribavirin on" exact="hepatitis" post="C virus RNA polymeraseBiochemistry200342104621047110.1021/bi034468112950173 68.Bassi, M. R., Sempere, R."/>
 <result pre="viruses via lethal mutagenesisFuture Virol2008355356610.2217/17460794.3.6.55319727424 71.BonnacLFManskyLMPattersonSEStructure-activity relationships and design of" exact="viral" post="mutagens and application to lethal mutagenesisJ Med Chem2013569403941410.1021/jm400653j23914828 72.FayMMLyonsSMIvanovPRNA"/>
</results>
